Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS
about
Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injuryGlia: an emerging target for neurological disease therapyMicroglia centered pathogenesis in ALS: insights in cell interconnectivityRecent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral SclerosisTransplanted glial restricted precursor cells improve neurobehavioral and neuropathological outcomes in a mouse model of neonatal white matter injury despite limited cell survival.Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells.Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment.Human glial progenitor engraftment and gene expression is independent of the ALS environmentOverexpression of the astrocyte glutamate transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury.Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord.Combined transplantation of GDAs(BMP) and hr-decorin in spinal cord contusion repair.Effect of type-2 astrocytes on the viability of dorsal root ganglion neurons and length of neuronal processes.Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS miceStem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI.Human iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury.Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS.Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis.Stem cell therapy for amyotrophic lateral sclerosisRegenerative cellular therapies for neurologic diseasesHuman astrocytes derived from glial restricted progenitors support regeneration of the injured spinal cordGlial-Restricted Precursors Protect Neonatal Brain Slices from Hypoxic-Ischemic Cell Death Without Direct Tissue ContactIntermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosisDistributed Features of Vimentin-Containing Neural Precursor Cells in Olfactory Bulb of SOD1G93A Transgenic Mice: a Study about Resource of Endogenous Neural Stem Cells.Astrocyte-like cells derived from human oral mucosa stem cells provide neuroprotection in vitro and in vivo.Bioengineered stem cells in neural development and neurodegeneration researchCellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS.Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?Stem cells therapy for ALS.Drugs in clinical development for the treatment of amyotrophic lateral sclerosis.Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosisFunctional and morphological assessment of diaphragm innervation by phrenic motor neurons.Transplantation of D15A-expressing glial-restricted-precursor-derived astrocytes improves anatomical and locomotor recovery after spinal cord injury.Motoneuron Disease: Clinical.Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis.Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody.Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.Translational Research in Stem Cell Treatment of Neuromuscular Diseases
P2860
Q26825854-90788560-BAEF-4ED6-B255-8E9551D4EE45Q27000259-1EFF287B-C7B5-468D-81A3-B751DB90D4C0Q27009559-7B5CB152-74E2-4999-8B0C-13D01B8FE69FQ27338320-C6000520-A618-4E7D-B393-17C8342385CCQ30389642-01ACA9C0-FFF5-4A85-9DE9-7E54C3502E7DQ30413268-F1A874B9-61F2-42EE-B0FD-571447D4B9FFQ33552001-BE5502CD-9713-4093-8519-3322BE8FBEAFQ33620690-88CEA6CA-D65D-4E8F-B090-1B4390F5F6D5Q33671711-EAC8066E-6CE1-46E4-8B15-390119DEAA6EQ33804981-7F308FEA-32D6-41B0-BAF8-B95ED4B2A54BQ34095157-149788D5-51DE-4BE2-BBCB-D83FA3BFBCDAQ34095690-E4E47319-6E88-4542-AFB9-8694184B6D49Q34246088-E1B0F199-BA8A-4FE1-8EF5-53042793B7D5Q35087066-88495FFA-D996-4786-9D24-FCD934D7E03FQ35153113-0D3BC064-DE19-4132-A50B-35ED5B500DC6Q35717943-3B30C80A-87C4-4D58-B9FF-3D06B1F75B4FQ36278903-A6EF10D0-E3BB-46A0-9A4F-805019BA89FFQ36299228-5D7E82F7-1F6F-46CC-924D-0E357B85D7D4Q36301821-484E508C-F8A7-4FD0-B601-B7D00FAD07FCQ36522668-E9619538-45F3-4349-8EAC-90CEB4137150Q36947673-F5FDC0A7-1352-4096-B733-4CDF2D275CA5Q37061164-82F5AD68-7FE9-4FD1-8780-4B9EBEC1EEFBQ37070017-764460F8-61B6-47B4-AB7F-A20B49CB4CA1Q37513881-30EDF717-D01E-48A9-9F86-37688B7EC1CBQ37635458-ACD0DD6A-F6BC-4D52-9E2A-43E6CFD29392Q38104829-96B778E6-3C1F-4660-9A4C-7C7DC1071D77Q38150127-65307795-3D2A-4E34-A54C-38C721E2D496Q38171484-37D1A151-4EE3-4097-9218-73B9202D1EBCQ38265205-EF28CDC4-9BF9-4172-9C41-8181AC9D6D71Q38630465-92C688D0-EB75-4D87-AA98-3A1EC2430801Q38748144-4DBDFCF1-03C8-41CC-A6B7-2955930A4A86Q40884175-B2B27B00-7956-42B7-9F54-D221497CCFE6Q41775898-8BAC5368-119B-43ED-856A-0BDC45490324Q42522439-F8C55B7F-BE9B-4568-A155-AC31BF6E61D8Q45869420-FD825F70-268F-4895-843A-BECE81206F21Q48228453-4ECBB583-E99D-4BA1-9482-1D490E35439DQ49819864-1EACE565-95C4-4FEE-A879-05706D474498Q50980710-9DA75647-CA68-45F8-B156-94664B6D1835Q51012646-2E833915-DF59-4D44-AE72-06A9A4F492FEQ59001351-4FFAAA1D-B508-46A5-984A-4CAAA103E8BE
P2860
Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@ast
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@en
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@nl
type
label
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@ast
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@en
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@nl
prefLabel
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@ast
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@en
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@nl
P2093
P2860
P1433
P1476
Human glial-restricted progeni ...... of the SOD1 mouse model of ALS
@en
P2093
Alicia Tuteja
Andrew S Kim
Angelo C Lepore
James T Campanelli
Linda L Kelley
Mahendra S Rao
Nicholas J Maragakis
Timothy Williams
P2860
P304
P356
10.1371/JOURNAL.PONE.0025968
P407
P577
2011-01-01T00:00:00Z